Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. (ENZN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENZN · as of Jun 9, 2026
Key Statistics
Explore Enzon Pharmaceuticals, Inc. Data
enzn stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
enzn competitorsENZN
CLABF
CTABF
DOSEF
FAMDF
FNAMStock Performance
Full HistoryAbout Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. along with its various subsidiaries, primarily focuses on the commercialization of pharmaceutical products. PegIntron is a key drug within its actively marketed portfolio.…
what is enzon pharmaceuticals, inc. · enzn stock overview · enzon pharmaceuticals, inc. company profile · who is enzon pharmaceuticals, inc. ceo · enzn OTC · enzon pharmaceuticals, inc. headquarters · enzon pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Enzon Pharmaceuticals, Inc. (ENZN) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 15, 1984. As of the latest trading session, ENZN stock price is $5.75, with a market capitalization of $4.3M. The stock has returned -31.87% over the past 12 months and +51.72% year-to-date.
In fiscal year 2025, Enzon Pharmaceuticals, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enzon Pharmaceuticals, Inc. (ENZN) stock price is $5.75. The stock is traded on OTC under the ticker symbol ENZN. The 52-week range is $0.02 – $8.55.